Assay News and Research

RSS
Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

Abacus Diagnostica's new multiplex assay provides reliable influenza, COVID-19 diagnosis in 75 minutes

New graphical tool to identify potent neutralizing antibodies against SARS-CoV-2

New graphical tool to identify potent neutralizing antibodies against SARS-CoV-2

Researchers use fruit fly to develop a novel disease model for Pitt-Hopkins syndrome

Researchers use fruit fly to develop a novel disease model for Pitt-Hopkins syndrome

SARS-CoV-2 re-infection is real but rare: Case study

SARS-CoV-2 re-infection is real but rare: Case study

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

BAT study analyzes the toxicological impact of nicotine pouch products

BAT study analyzes the toxicological impact of nicotine pouch products

Bacteria-free method for making SARS-CoV-2 infectious clones

Bacteria-free method for making SARS-CoV-2 infectious clones

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

Complex SARS-CoV-2 serology means universal immunological assay is not feasible

FDA issues emergency use authorization for first serology point-of-care test for COVID-19

FDA issues emergency use authorization for first serology point-of-care test for COVID-19

Siemens’ SARS-CoV-2 antibody immunoassays meet regulatory targets

Siemens’ SARS-CoV-2 antibody immunoassays meet regulatory targets

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

Study on domestic cats and dogs in COVID-19+ households

Study on domestic cats and dogs in COVID-19+ households

No discernable difference in SARS-CoV-2 viral loads of young children versus older children and adults

No discernable difference in SARS-CoV-2 viral loads of young children versus older children and adults

UV-C irradiation rapidly inactivates SARS-CoV-2 on surfaces

UV-C irradiation rapidly inactivates SARS-CoV-2 on surfaces

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

SARS-CoV-2 seroprevalence in Swiss schoolchildren shows most infections undiagnosed

SARS-CoV-2 seroprevalence in Swiss schoolchildren shows most infections undiagnosed

COVID-19 mitigation efforts significantly decrease influenza activity

COVID-19 mitigation efforts significantly decrease influenza activity

Oncology nurses should be routinely tested for SARS-CoV-2, warn researchers

Oncology nurses should be routinely tested for SARS-CoV-2, warn researchers

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19